Drug shortages: Implications for medical toxicology

References

• Kweder SL, Dill S. Drug shortages: the cycle quantity and quality. Clin Pharmacol Ther 2013; 93:245–251.
   PubMed Web of Science ®Google Scholar
• Johnson TJ. Drug shortages: an increasing problem for patients and clinicians. S D Med 2011; 64:14–15.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Drug Shortages. Available from: http://www.fda.gov/Drugs/Drug-Safety/DrugShortages/default.htm. Accessed on October 15, 2014.
   Google Scholar
• U.S. Food and Drug Administration. A Review of FDA's Approach to Medical Product Shortages. Available from:http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm277755.pdf. Accessed on October 18, 2014.
   Google Scholar
• Boulis A, Goold S, Ubel PA. Responding to the immunoglobulin shortage: a case study. J Health Polit Policy Law 2002; 27:977–999.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Office of New Drugs, Drug Shortage Management. Manual of Policies and Procedures. Available from http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ManualofPoliciesProcedures/ucm079936.pdf. Accessed on October 15, 2014.
   Google Scholar
• Johnson TJ. Drug shortages: an increasing problem for patients and clinicians. S D Med 2011; 64:14–15.
   PubMedGoogle Scholar
• Kaiser J. Medicine: shortages of cancer drugs put patients, trials at risk. Science 2011; 332:523.
   PubMed Web of Science ®Google Scholar
• Rosoff PM. Unpredictable drug shortages: an ethical framework for short-term rationing in hospitals. Am J Bioeth 2012; 12:1–9.
   PubMed Web of Science ®Google Scholar
• Cherici C, Frazier J, Feldman M, Gordon B, Petrykiw CA, Russell WL, et al. Navigating Drug Shortages in American Healthcare: A Premier Healthcare Alliance Analysis. 2011. Available from: https://legacy.premierinc.com/about/news/11-mar/drug-shortage-white-paper-3-28-11.pdf. Accessed on October 14, 2014.
   Google Scholar
• Johnson LA, Associated Press. Drug Shortage Stirs Fear. Philly.com. 2011. Available from http://www.ismp.org/sc?k = dssf. Accessed on Mar 15, 2014.
   Google Scholar
• Woodcock J, Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther 2013; 93:170–176.
   PubMed Web of Science ®Google Scholar
• Becker DJ, Talwar S, Levy BP, Thorn M, Roitman J, Blum LH, et al. Impact of oncology drug shortages on patient therapy: unplanned treatment changes. J Oncol Pract 2013; 9:e122–e128.
   PubMedGoogle Scholar
• Eastman P. Oncology drug shortages worsening, threatening patient care. Oncol Times 2013; 33:14–15.
   Google Scholar
• Gatesman ML, Smith TJ. The shortage of essential chemotherapy in the United States. N Engl J Med 2011; 365:1653–1655.
   PubMed Web of Science ®Google Scholar
• Mazer-Amirshahi M, Pourmand A, Singer S, Pines JM, van den Anker J. Critical drug shortages: implications for emergency medicine. Acad Emerg Med 2014; 21:704–711.
   PubMed Web of Science ®Google Scholar
• Neavyn MJ, Boyer EW, Bird SB, Babu KM. Sodium acetate as a replacement for sodium bicarbonate in medical toxicology: a review. J Med Toxicol 2013; 9:250–254.
   PubMedGoogle Scholar
• American Society of Health-System Pharmacists. ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems.Am J Health Syst Pharm 2009; 66:1399–1406.
   PubMedGoogle Scholar
• Fox ER, Tyler LS. Managing drug shortages: seven years’ experience at one health system. Am J Health Syst Pharm 2003; 60:245–253.
   PubMed Web of Science ®Google Scholar
• United States Government Accountability Office. Drug Shortages: Public Health Threat Continues Despite Efforts to Help Ensure Product Availability. Available from: http://www.gao.gov/products/GAO-14–194. Accessed on October 10, 2014.
   Google Scholar
• United States Government Accountability Office. Drug Shortages FDA's Ability to Respond Should Be Strengthened. Available from: http://www.gao.gov/assets/590/587000.pdf. Accessed on November 10, 2014.
   Google Scholar
• Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV.Opioid epidemic in the United States. Pain Physician 2012; 15:ES9–38.
   Google Scholar
• Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011; 30:264–270.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. 2012. Available from: http://www.samhsa.gov/data/nsduh/2k11results/nsduhresults2011.htm. Accessed on November 1, 2014.
   Google Scholar
• Rudd RA, Paulozzi LJ, Bauer MJ, Burleson RW, Carlson RE, Dao D, et al. Increases in heroin overdose deaths-28 states, 2010–2012. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2014; 63:849–854.
   PubMed Web of Science ®Google Scholar
• Goodman DJ. Naloxone, a drug to stop heroin deaths, is more costly, the police say. New York Times. 2014. http://www.nytimes.com/2014/12/01/nyregion/prices-increase-for-antidote-to-heroin-overdoses-used-by-police.html. Accessed on November 20, 2014.
   Google Scholar
• Doyon S, Aks SE, Schaeffer S. Expanding naloxone access in the United States. Clin Toxicol 2014; 6:1–4.
   Google Scholar
• Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med 2003; 348:1786–1795.
   PubMed Web of Science ®Google Scholar
• Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence based practice guideline: American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 1997; 278: 144–151.
   PubMed Web of Science ®Google Scholar
• Institute for Safe Medication Practices. Medication Safety Alert. Drug Shortages Threaten Patient Safety. 2010. Available from: http://www.ismp.org/newsletters/acutecare/articles/20100729.asp. Accessed on November 15, 2014.
   Google Scholar
• Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D 2013; 13:1–8.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. FDA Safety and Innovation Act (FDASIA) Title X. 2012. Available from: http://www.gpo.gov/fdsys/pkg/BILLS-112s3187enr/pdf/BILLS-112s3187enr.pdf. Accessed on November 15, 2014.
   Google Scholar
• U.S. Food and Drug Administration. Strategic Plan for Mitigating and Preventing Drug Shortages. 2013. Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM372566.pdf. Accessed on November 15, 2014.
   Google Scholar
• Hamburg, M. FDA Voice. Six Month Check-up: FDA's Work on Drug Shortages. Available from: http://blogs.fda.gov/fdavoice/index.php/2012/05/six-month-check-upfdas-work-on-drug-shortages. Accessed on November 15, 2014.
   Google Scholar
• Tyler LS, Fox ER, Caravati EM. The challenge of drug shortages for emergency medicine. Ann Emerg Med 2002; 40:598–602.
   PubMed Web of Science ®Google Scholar
• American College of Medical Toxicology Position Statements. Antidote shortages: impact and response. Available from: http://www.acmt.net/cgi/page.cgi/zine_service.html?aid=4081&zine=show. Accessed on April 1, 2015.
   Google Scholar
• Dart RC, Borron SW, Caravati EM, Cobaugh DJ, Curry SC, Falk JL, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med 2009; 54: 386–394.e1.
   PubMed Web of Science ®Google Scholar